Petrus Trust Company’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,060
Closed -$480K 611
2024
Q4
$480K Buy
4,060
+1,933
+91% +$226K 0.05% 233
2024
Q3
$235K Buy
+2,127
New +$222K 0.02% 482
2023
Q4
Sell
-3,536
Closed -$307K 612
2023
Q3
$307K Buy
+3,536
New +$320K 0.03% 381
2019
Q4
Sell
-5,745
Closed -$271K 291
2019
Q3
$271K Buy
+5,745
New +$262K 0.05% 122
2018
Q3
Sell
-6,701
Closed -$327K 257
2018
Q2
$327K Buy
6,701
+3,076
+85% +$174K 0.07% 104
2018
Q1
$227K Sell
3,625
-711
-16% -$48.8K 0.05% 122
2017
Q4
$266K Buy
4,336
+934
+27% +$57.7K 0.07% 114
2017
Q3
$228K Buy
+3,402
New +$240K 0.05% 135
2017
Q1
Sell
-3,501
Closed -$252K 184
2016
Q4
$252K Buy
+3,501
New +$253K 0.06% 119

Other funds holding CAH

Petrus Trust Company's CAH Position: Q1 2025 in Review

Petrus Trust Company sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 4,060 shares — an estimated $480K sold.

Petrus Trust Company first reported a position in CAH in Q4 2016 and held it in 9 quarters. The position peaked at $480K in Q4 2024. 1,148 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

  • Petrus Trust Company reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
  • Petrus Trust Company sold 4,060 Cardinal Health shares in Q1 2025, an estimated $480K.
  • Petrus Trust Company first reported a position in Cardinal Health in Q4 2016 and held it in 9 quarters.
  • Petrus Trust Company's Cardinal Health position peaked at $480K in Q4 2024.
  • 1,148 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on Petrus Trust Company's 13F filing for Q1 2025, filed 15 May 2025.